Document |
Document Title |
WO/2019/151769A1 |
The present disclosure relates to a method for preparing L-cysteine hydrochloride hydrate crystals, and L-cysteine hydrochloride hydrate crystals prepared by the method. Through the method for preparing L-cysteine hydrochloride hydrate c...
|
WO/2019/152765A1 |
The present disclosure relates to compositions of N-acetylcysteine for use in treating aortic stenosis. Methods of treating aortic stenosis in a subject comprising administering to said subject an effective amount of N-acetylecysteine (N...
|
WO/2019/151770A1 |
The present disclosure relates to a method for preparing L-cysteine crystals, and L-cysteine crystals prepared by the method. Through the method for preparing L-cysteine crystals of the present disclosure, L-cysteine crystals can be obta...
|
WO/2019/149091A1 |
The present invention relates to the field of compounds, and in particular to a probucol derivative, a preparation method therefor and use thereof, the probucol derivative having a structure represented by general formula I. The probucol...
|
WO/2019/131590A1 |
The purpose of the present invention is to provide a refined methionine production method which can achieve an improvement in washing efficiency. This method is for producing refined methionine from a slurry of unrefined methionine, and ...
|
WO/2019/131726A1 |
The purpose of the present invention is to provide a method for producing methionine, the method making it possible to efficiently recover ammonia from a gas evolved by concentrating a mother liquor and utilize the ammonia. The productio...
|
WO/2019/119067A1 |
The present invention relates to TLR2 agonist compounds and their compositions, and the use of such compounds and compositions in the prevention and/or treatment of respiratory infections, or diseases or conditions associated with viral ...
|
WO/2019/119785A1 |
Disclosed in the present invention is a preparation method for 4-phenylthio-benzenethiol. The preparation method comprises the following steps: subjecting phenyl sulfide as a raw material to a halogenation reaction to obtain 4-halophenyl...
|
WO/2019/124370A1 |
The purpose of the present invention is to provide a method for manufacturing methionine, whereby enhanced efficiency of ammonia removal can be achieved. This manufacturing method includes a removal step for reacting 3-methylmercaptoprop...
|
WO/2019/117180A1 |
The purpose of the present invention is to provide a method for producing methionine that takes environmental considerations into account. The production method according to the present invention comprises: a removal step for blowing an ...
|
WO/2019/111845A1 |
The present invention addresses the problem of providing a polar compound which exhibits high chemical stability, high ability to align liquid crystal molecules, high solubility in a liquid crystal composition and a high voltage retentio...
|
WO/2019/109188A1 |
The present application is directed to compounds of Formula (I)-(VI): (I), (II), (III), (IV), (V) (VI), (VII) and (VIII), compositions comprising these compounds and their uses, for example as medicaments and/or diagnostics.
|
WO/2019/106029A1 |
The present invention relates to norbornadiene compounds (Formula I), and the corresponding quadricyclane compounds (Formula III). The compounds are to be included in a molecular thermal systems (MOST), and to be used for storing solar e...
|
WO/2019/107533A1 |
The present invention provides a compound for suppressing cell transformation, the compound being represented by the following general formula (wherein n is 1 or 2; R1 is H, methoxy(-OCH3), or Cl; R2 is H, -OCH3, or Cl; R3 is H, -OCH3, C...
|
WO/2019/102054A1 |
Non-glycosidic analogues of alpha-galactosylceramide of formula (I), wherein A, Z, Ra, Rb and Rc have the meaning indicated in the description, as NKT cell activators.
|
WO/2019/101132A1 |
Disclosed in the present invention are a fluorosulfonyl-containing compound, an intermediate thereof, a preparation method therefor and use thereof. The fluorosulfonyl-containing compound disclosed in the present invention comprises a ca...
|
WO/2019/096868A1 |
The invention relates to compounds of a new type which have a stabilizing effect and in particular provide stabilization with respect to oxidative thermal and/or actinic decomposition of or damage to organic materials. The compounds are ...
|
WO/2019/097434A1 |
The aspects of the present disclosure relates to novel lanosterol derivatives and novel 25-hydroxycholesterol derivatives including their pharmaceutically acceptable salts as well as methods of treatment and pharmaceutical compositions a...
|
WO/2019/099761A1 |
Disclosed are solid state forms of Elafibranor and salts thereof, processes for preparation thereof and pharmaceutical compositions thereof.
|
WO/2019/096884A1 |
The invention relates to benzoyl amides of general formula (I), as herbicides. In formula (I), B is N or CH, and X1 and X2 are O or S(O)n. R, Ra and Rb are groups such as hydrogen, halogen, (C1-C6)-alkyl, halogen-(C1-C6)-alkyl, (C1-C6)-a...
|
WO/2019/096325A1 |
The present invention relates to a bisamide complex, and a method for quickly detecting organophosphate and carbamate pesticides. The complex prepared in the present invention can effectively detect trace quantities of organophosphate an...
|
WO/2019/087985A1 |
The purpose of the present invention is to obtain: a cured film that has high sensitivity, enables formation of a pattern of a low-tapered shape after development, is capable of suppressing a change in the dimensional width of pattern op...
|
WO/2019/071353A1 |
A method of reducing glutamate efflux from skeletal muscle by inhibiting system Xc- activity is provided. The method is useful for the treatment of statin-induced myalgia. Pharmaceutical compositions useful to treat statin-induced myalgi...
|
WO/2019/074803A1 |
This disclosure concerns a method of making a ligand for Quantum Dot functionalization, a method of making a functionalized Quantum Dot (QD) with a ligand, and a method of making a transparent luminescent quantum dot thiol-yne nanocompos...
|
WO/2019/063952A1 |
The invention relates to a new method for the synthesis of unsymmetrical tertiary amines using alcohol and an imine, and to new tertiary amines.
|
WO/2019/060634A1 |
The invention features methods for the treatment of cystinosis and other cysteamine sensitive disorders in a subject including administration of a disulfide convertible to cysteamine in vivo. The methods can include the separate administ...
|
WO/2019/060623A1 |
The present invention includes methods for making and isolating N-acetylcysteine amide, intermediates and derivatives thereof comprising: contacting cystine with an alcohol and a chlorinating reagent to form an organic solution containin...
|
WO/2019/043604A1 |
The invention relates to peptide conjugates, methods for making peptide conjugates, conjugates produced by the methods, and pharmaceutical compositions comprising the conjugates. Methods of eliciting immune responses in a subject and met...
|
WO/2019/025540A1 |
The invention relates to 3-acyl-benzamides of formula (I) as herbicides. In formula (I) X, Y, Z and Rx represent radicals such as alkyl, cycloalkyl and halogen.
|
WO/2019/025017A1 |
The present invention relates to a process for the preparation of elafibranor and novel synthesis intermediates.
|
WO/2019/026994A1 |
The present invention provides a pharmaceutical composition for the treatment or prevention of cognitive function diseases or disorders, wherein the pharmaceutical composition contains a compound represented by formula (I), an enantiomer...
|
WO/2019/025498A1 |
The present invention relates to catechol-derivative compounds of formula (I), as well as polymeric compounds obtained by condensation. The present invention also relates to the use of the compounds for preparing functional coatings and ...
|
WO/2019/018892A1 |
There is provided a range of novel disulfide bond containing compounds. These disulfide bond containing compounds can be used in a variety of applications such as solid phase peptide synthesis, solid phase organic synthesis, formation of...
|
WO/2019/021758A1 |
With the purpose of the present invention being to provide a resist material having high coating film smoothness and uniformity, and excellent resolution or other patterning performance, a resist material is provided that contains a cali...
|
WO/2019/017415A1 |
The present invention addresses the problem of providing a method for producing purified methionine, the method being capable of preventing the caking of methionine. The present invention pertains to a method for producing purified methi...
|
WO/2019/016354A1 |
The invention relates to a novel amino acid having a norbornene group and polypeptide comprising the novel amino acid compounds. The invention also relates to a method of producing polypeptides comprising a norbornene group and to the us...
|
WO/2019/013299A1 |
The present invention provides a thermally conductive material that has excellent thermal conductivity. The present invention also provides: a device that is provided with a thermally conductive layer that includes the thermally conducti...
|
WO/2019/008156A1 |
The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-1/PD-L1 protein/protein interaction. The compounds may be used in the treatment of cancer, infectious diseases and neurodegenerative di...
|
WO/2019/001361A1 |
A piperic acid derivative and preparation and an application thereof. The structure of the derivative is as shown in general formula I. The compound of general formula I has excellent pesticidal, miticidal, and bactericidal activities an...
|
WO/2018/233562A1 |
The present invention relates to an intermediate for preparing oseltamivir and an isomer thereof. The intermediate of the present invention is prepared by means of neighboring group participation at room temperature under the conditions ...
|
WO/2018/229083A1 |
The present invention relates to compounds, in particular those of formula (I) and formula (II) described herein, or pharmaceutically acceptable salts or solvates thereof, which may be used as radioligands in in vitro, ex vivo and in viv...
|
WO/2018/227840A1 |
The present application relates to a methionine production method for reducing by-product sodium sulfate, comprising: adding sodium carbonate or a mixture of sodium carbonate and sodium hydroxide into 5-(2-methylthioethyl)-hydantoin aque...
|
WO/2018/227839A1 |
The present application relates to an environment-friendly production method for methionine, comprising: hydrolyzing 5-(2-methylthioethyl)-hydantoin with sodium carbonate, then performing sodium carbonate crystallization, performing soli...
|
WO/2018/225790A1 |
The present application discloses a crystal of an oxidized glutathione dication salt and a production method for the crystal.
|
WO/2018/215206A1 |
The present invention relates to a process for preparing methionine comprising the hydrolysis of 5-(2-methylmercaptoethyl)hydantoin (methionine hydantoin) in an alkaline process solution in which by-products comprising formate and other ...
|
WO/2018/212149A1 |
The invention of the present application provides a pneumatic conveyance method for methionine that can suppress crush of methionine to a minimum, the method being characterized in that, when pneumatically conveying methionine using carr...
|
WO/2018/210615A1 |
The present invention relates to a process for preparing methionine, comprising the alkaline hydrolysis of 5-(2-methylmercaptoethyl)-hydantoin (methionine hydantoin) in an aqueous process solution comprising alkali metal hydroxide and/or...
|
WO/2018/208709A1 |
The present application discloses stilbene derivative compounds and compositions, and methods for treating ocular diseases, neurological disorders and protein aggregation-related disorders in patients using the compounds and compositions...
|
WO/2018/199292A1 |
The invention of the present application provides a recovered-carbon-dioxide purifying method in which, by bringing a carbon dioxide gas containing at least 3-methylmercapto-propionaldehyde and acrolein into contact with activated carbon...
|
WO/2018/199294A1 |
The present invention provides a methionine production method characterized by including: a step in which 5–[2–(methylthio) ethyl] imidazolidine–2,4–dione is hydrolyzed in the presence of an alkali compound and a reaction liquid ...
|